Collplant Biotechnologies Ltd
NASDAQ:CLGN

Watchlist Manager
Collplant Biotechnologies Ltd Logo
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Watchlist
Price: 3.44 USD 0.88%
Market Cap: 39.4m USD
Have any thoughts about
Collplant Biotechnologies Ltd?
Write Note

Collplant Biotechnologies Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Collplant Biotechnologies Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Total Current Assets
$28m
CAGR 3-Years
70%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Total Current Assets
$164.4m
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
5%
Enlivex Therapeutics Ltd
NASDAQ:ENLV
Total Current Assets
$28.6m
CAGR 3-Years
-32%
CAGR 5-Years
8%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Total Current Assets
$295.1m
CAGR 3-Years
33%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Total Current Assets
$7.3m
CAGR 3-Years
-36%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Total Current Assets
â‚Ş14.6m
CAGR 3-Years
-44%
CAGR 5-Years
55%
CAGR 10-Years
15%
No Stocks Found

Collplant Biotechnologies Ltd
Glance View

Market Cap
39.4m USD
Industry
Biotechnology

CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

CLGN Intrinsic Value
15.33 USD
Undervaluation 78%
Intrinsic Value
Price

See Also

What is Collplant Biotechnologies Ltd's Total Current Assets?
Total Current Assets
28m USD

Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Total Current Assets amounts to 28m USD.

What is Collplant Biotechnologies Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
31%

Over the last year, the Total Current Assets growth was -11%. The average annual Total Current Assets growth rates for Collplant Biotechnologies Ltd have been 70% over the past three years , 31% over the past five years .

Back to Top